SEC filing record
Primary Source · SEC.gov

Adagio Medical Holdings, Inc.

2025 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalNew Form D filerForm D · 2025-10-29Last filing 2025-10-29

Raised

$19M

Investors

16

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Adagio Medical Holdings, Inc. is a Delaware corporation that filed a Form D with the SEC on October 29, 2025 in the Other Health Care industry group. The offering claims Rule 506(b) and covers equity. Adagio Medical Holdings, Inc. reported $18,999,999 sold from 16 investors of a $49,846,793 total offering as of the Form D filed October 29, 2025. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names Piper Sandler & Co. (CRD 665), associated with None as the recipient of sales compensation soliciting in CA, CO, CT, FL, GA, IL, MA, MD, NY, PA, TX, UT, WA, WI. Sales commissions are reported as $0 and finders' fees as $1,245,000. Form D allows these to be estimates. The issuer's address of record is 26051 Merit Circle, Suite 102, Laguna Hills, CA 92653.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002006986
Entity NameAdagio Medical Holdings, Inc.
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeCorporation
Jurisdiction of OrganizationDelaware
Issuer Address26051 Merit Circle, Suite 102, Laguna Hills, CA 92653
Phone(949) 348-1188
Former NamesAja Holdco, Inc. (until August 1, 2024)
Industry / Fund TypeOther Health Care
Securities TypeEquity
First Sale DateOctober 17, 2025
Filing DateOctober 29, 2025
Accession Number0001231919-25-000371
Total Offering Amount$49,846,793
Total Amount Sold$18,999,999
Amount Remaining$30,846,794
Amount Sold NoteCombined figure across related vehicles: Total offering amount assumes exercise of all pre-funded and tranche warrants. Amount remaining to be sold reflects aggregate exercise price of warrants
Total Investors16
Non-Accredited InvestorsNone
Minimum Investment$0 (no stated minimum)
Offering DurationOne year or less
Sales Commissions$0 (to Piper Sandler & Co.)
Finders' Fees$1,245,000
Revenue RangeDecline to Disclose
State (Issuer Address)CA
Amendment CountOriginal filing only

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

1

latest Oct 29, 2025

Critical / warning

0 / 0

0 watch · 1 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

raising

Latest event New filer · Oct 29, 2025

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Fund family Part of the ADAGIO MEDICAL family: 2 vehicles across 0 generations · full family and the filing behind each link in the terminal

Investor

  • The full fund family and any related vehicles (parallel, feeder, successor, sibling series) with the filing that shows each link
  • 1 filing event with values and deltas, latest 2025-10-29, and alerts on the next one
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Todd Usen

Executive Officer, Director · Laguna Hills, CA

Deborah Kaster

Executive Officer · Laguna Hills, CA

Orly Mishan

Director · Laguna Hills, CA

James L. Cox

Director · Laguna Hills, CA

Timothy P. Moran

Director · Laguna Hills, CA

Sandra P. Gardiner

Director · Laguna Hills, CA

Keyvan P. Mirsaeedi-Farahani

Director · Laguna Hills, CA

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

Piper Sandler & Co.CRD 665 on BrokerCheck

Associated broker-dealer: None · New York, NY · Soliciting in CA, CO, CT, FL, GA, IL, MA, MD, NY, PA, TX, UT, WA, WI

Questions About Adagio Medical Holdings, Inc.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Adagio Medical Holdings, Inc.?

Adagio Medical Holdings, Inc. is a Delaware corporation that filed a Form D with the SEC on October 29, 2025 in the Other Health Care industry group. The filing claims Rule 506(b) for an offering of equity.

Is Adagio Medical Holdings, Inc. legit?

AltStreet does not rate legitimacy; it reports the public record. Adagio Medical Holdings, Inc. filed a Form D with the SEC on October 29, 2025 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $18,999,999 sold to 16 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Adagio Medical Holdings, Inc. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Adagio Medical Holdings, Inc. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Adagio Medical Holdings, Inc. raised?

Adagio Medical Holdings, Inc. reported $18,999,999 sold from 16 investors of a $49,846,793 total offering as of the Form D filed October 29, 2025. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone.

Who can invest in Adagio Medical Holdings, Inc.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.

What is the minimum investment in Adagio Medical Holdings, Inc.?

The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.

Who is selling Adagio Medical Holdings, Inc. and how are they paid?

The Form D names Piper Sandler & Co. (CRD 665), associated with None as the recipient of sales compensation soliciting in CA, CO, CT, FL, GA, IL, MA, MD, NY, PA, TX, UT, WA, WI. Sales commissions are reported as $0 and finders' fees as $1,245,000. Form D allows these to be estimates.

Who is behind Adagio Medical Holdings, Inc.?

The Form D lists 7 related persons: Todd Usen, executive officer, director; Deborah Kaster, executive officer; Orly Mishan, director; James L. Cox, director; Timothy P. Moran, director; Sandra P. Gardiner, director; Keyvan P. Mirsaeedi-Farahani, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Adagio Medical Holdings, Inc. located?

The issuer's address on its SEC filings is 26051 Merit Circle, Suite 102, Laguna Hills, CA 92653. Its phone number of record is (949) 348-1188. It is organized under the laws of Delaware.

How long is the Adagio Medical Holdings, Inc. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

What is Adagio Medical Holdings, Inc.'s revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.